1. Home
  2. HCM vs BSM Comparison

HCM vs BSM Comparison

Compare HCM & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • BSM
  • Stock Information
  • Founded
  • HCM 2000
  • BSM 1876
  • Country
  • HCM Hong Kong
  • BSM United States
  • Employees
  • HCM N/A
  • BSM N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • BSM Oil & Gas Production
  • Sector
  • HCM Health Care
  • BSM Energy
  • Exchange
  • HCM Nasdaq
  • BSM Nasdaq
  • Market Cap
  • HCM 2.5B
  • BSM 2.8B
  • IPO Year
  • HCM N/A
  • BSM 2015
  • Fundamental
  • Price
  • HCM $17.59
  • BSM $12.22
  • Analyst Decision
  • HCM Buy
  • BSM Hold
  • Analyst Count
  • HCM 2
  • BSM 1
  • Target Price
  • HCM $23.50
  • BSM $14.00
  • AVG Volume (30 Days)
  • HCM 60.7K
  • BSM 595.4K
  • Earning Date
  • HCM 08-07-2025
  • BSM 08-04-2025
  • Dividend Yield
  • HCM N/A
  • BSM 12.39%
  • EPS Growth
  • HCM N/A
  • BSM N/A
  • EPS
  • HCM 0.04
  • BSM 0.92
  • Revenue
  • HCM $630,201,000.00
  • BSM $422,061,000.00
  • Revenue This Year
  • HCM $14.86
  • BSM $12.15
  • Revenue Next Year
  • HCM $19.54
  • BSM $13.03
  • P/E Ratio
  • HCM $77.78
  • BSM $13.17
  • Revenue Growth
  • HCM N/A
  • BSM N/A
  • 52 Week Low
  • HCM $11.51
  • BSM $11.98
  • 52 Week High
  • HCM $21.50
  • BSM $15.74
  • Technical
  • Relative Strength Index (RSI)
  • HCM 66.22
  • BSM 26.16
  • Support Level
  • HCM $15.95
  • BSM $13.10
  • Resistance Level
  • HCM $17.97
  • BSM $13.39
  • Average True Range (ATR)
  • HCM 0.32
  • BSM 0.24
  • MACD
  • HCM 0.14
  • BSM -0.10
  • Stochastic Oscillator
  • HCM 83.59
  • BSM 7.86

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About BSM Black Stone Minerals L.P. Common units representing limited partner interests

Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.

Share on Social Networks: